Priti Patnaik is the founding editor of Geneva Health Files, a reporting initiative that tracks the governance of global health, reporting on power and politics in international health policy. She has reported on finance, banking and commodities, for different publications in Geneva, New York and New Delhi during the last 15 years.

Basic information

Priti Patnaik
International health policy, finance, banking and commodities

Supported projects

Behind The Pledge - How EU money is spent for Covid19 drugs

  • Healthcare
  • Industry

BRUSSELS - How did we come to pay gold for a drug whose effectiveness has not been proven? This is the story of Remdesivir, a drug developed by the American company Gilead Sciences with large public funds to combat Ebola, and in July approved by the European Medicines Agency with "conditional authorisation" as the first antiviral against Covid 19.